The scaremonger continues his strategy, page-13

‘other losers would just prefer to make flippant remarks as usual’ ~ @bid

How can someone like you @bid be so wrong, so often but yet still attack posters that have a different opinion?

‘It has only strengthened my personal opinion that DEP-Docetaxel will be a dud. They should fess up to shareholders, suspend further recruitment, bank the data, save money and move on to the more promising internal drug development.’ ~ @sarge17 July 2022

Starpharma finally announce the extraordinarily long-overdue DEP-Docetaxel Ph2 results in Dec 2023

’Fantastic announcement and should silence those who thought DEP doc was a dead duck. To the believers well done. To the doubters I don’t want to say I told you so but I told you so’ ~ @bid Dec 2023

May 2024 - Starpharma puts DEP-Docetaxel ‘in the bin’

Flippant remarks indeed.